Orthobiologics Market, By Products (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-rich Protein, and Bone Marrow Aspirate Concentrate), By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, Fracture Recovery, and Maxillofacial & Dental Applications), By End User (Hospitals, Orthopedic Clinics, and Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities) , and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI377819 | Publish Date: February 2024 | No. of Pages: 168

Global Orthobiologics Market By Products Overview

Orthobiologics Market was valued at US$ 9.2 Billion in 2024 and is projected to grow at a CAGR of 5.9% to reach US$ 15.5 Billion by 2034.Orthobiologics are substances that orthopedic surgeons uses to heal injuries more quickly. This substance are used to recover the healing of broken bones and injured muscles, tendons, and ligaments.

Common orthobiologics consist of platelet-rich plasma, bone marrow concentrate, certain fat grafts, and birth tissues. These are autologous or allogeneic substances. These type of products are made from substances that are naturally found in human body. When they are used in higher absorptions, orthobiologic substances support to speed up the healing process. Also provide a benefits such as include minimizing impact of degenerative disease, all procedures are completed in the workplace as an outpatient and recovery is more rapid than surgery.

Drivers and Restraints:

Increased in incidences of sports injury, road accidents, and osteoarthritis are the major factor driving the growth for target market. For instance according to ASIRT organization almost 1.25 million people die in road crashes each year, on average 3,287 deaths a day in addition around 20-50 million are injured or disabled. Additionally, growing geriatrics and obese population is likely to lead to significances, like greater incidences of osteoarthritis. For instance, according to WHO in 2018, worldwide obesity has nearly tripled since 1975. In addition in 2016, around 1.9 billion adults, were overweight and out of these above 650 million were obese. Furthermore, rise in awareness of orthobiologics and growth in demand for advanced treatment are other factors expected to boost target market growth. Moreover, high growth in developing nations and increase in demand for advanced treatment are predictable to create new opportunities for the target market. However, high cost of orthobiologics and some stringent rules for approval process are the major factor restrain the market growth.

Segmentation:

The global Orthobiologics market is segmented based products, application, end-user and region.

On the basis of products the global Orthobiologics market is segmented into viscosupplementation products, demineralized bone matrices, synthetic orthobiologics, bone morphogenic protein, allografts, plasma-rich protein, and bone marrow aspirate concentrate. By application, the global Orthobiologics market is segmented into osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries, fracture recovery, and maxillofacial and dental applications. Osteoarthritis and degenerative arthritis application segment is accepted to dominate the global market over the forecast period. According to WHO by 2050 people aged over 60 will account for more than 20% of the world’s population and the traditional estimate of 15% will have symptomatic OA and around one third percent of people where will be severely disabled. That’s means around 130 million people will suffer from OA worldwide, by 2050. By end user, the global Orthobiologics market is segmented into hospitals, orthopedic clinics, and ambulatory care centers, research and academic institutes, and dental clinics and facilities.

Based on region the global Orthobiologics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the target market. Owing to increasing prevalence of spinal disorders, rising geriatric and obese population, such factor drives the growth of target market in the region. Additionally rising preference for minimally invasive procedures. Asia-Pacific contribute for the significant share of the orthobiologics market, due to rise in geriatric population and surge in obesity. In addition increase in disposable income, with growth in research, development provide strong support for the target market. Additionally rise in road accident and increase prevalence of symptomatic OA drives the market growth in the region.

Key Players:

The key players operating the global Orthobiologics market involves Medtronic Plc, DePuy Synthes, Zimmer Biomet Stryker, Bioventus, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, NuVasive, SeaSpine, and Xtant Medical. The vendors in the market are focusing on research and development and innovation of new product.

Detailed Segmentation:

Orthobiologics Market, By Products:

  • Viscosupplementation Products
  • Demineralized Bone Matrices
  • Synthetic Orthobiologics
  • Bone Morphogenic Protein
  • Allografts
  • Plasma-rich Protein
  • Bone Marrow Aspirate Concentrate

Orthobiologics Market, By Application:

  • Osteoarthritis and Degenerative Arthritis
  • Spinal Fusion
  • Soft-tissue Injuries
  • Fracture Recovery
  • Maxillofacial and Dental Applications

Orthobiologics Market, By End-User:

  • Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
  • Research and Academic Institutes
  • Dental Clinics and Facilities

Global Orthobiologics Market, By Region:

      • North America
        • North America Orthobiologics Market, By Products
        • North America Orthobiologics Market, By Application
        • North America Orthobiologics Market, By End-User
        • North America Orthobiologics Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe Orthobiologics Market, By Products
        • Europe Orthobiologics Market, By Application
        • Europe Orthobiologics Market, By End-User
        • Europe Orthobiologics Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Orthobiologics Market, By Products
        • Asia Pacific Orthobiologics Market, By Application
        • Asia Pacific Orthobiologics Market, By End-User
        • Asia Pacific Orthobiologics Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific                                                                                                                                                                                         
      • Latin America
        • Latin America Orthobiologics Market, By Products
        • Latin America Orthobiologics Market, By Application
        • Latin America Orthobiologics Market, By End-User
        • Latin America Orthobiologics Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Orthobiologics Market, By Products
        • Middle East & Africa Orthobiologics Market, By Application
        • Middle East & Africa Orthobiologics Market, By End-User
        • Middle East & Africa Orthobiologics Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Company Profile:

  • Medtronic Plc*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • DePuy Synthes
  • Zimmer Biomet Stryker
  • Bioventus
  • Harvest Technologies
  • Globus
  • Orthofix International
  • RTI Surgical
  • K2M Group
  • Kuros Biosciences
  • NuVasive
  • SeaSpine
  • Xtant Medical

“*” marked represents similar segmentation in other categories in the respective section

Key Issues Addressed

  • What is the total revenue potential of the global the Orthobiologics market?
  • How that market is expected to grow during the study period?
  • What are some of the major growth opportunities in the Orthobiologics market?
  • Which companies are the major players in the Orthobiologics market?

FAQs

The Orthobiologics market is segmented into Type, Application, and Region.

Emerging trends include the development of novel orthobiologic products, increasing applications in orthopedic surgeries, and advancements in regenerative medicine, presenting significant opportunities in the global Orthobiologics Market.

Factors driving the market include the rising prevalence of musculoskeletal conditions, advancements in biotechnology and stem cell research, the demand for minimally invasive orthopedic treatments, and the focus on accelerated healing and reduced recovery times.

The report covers regions worldwide. North America is expected to dominate the Orthobiologics Market, driven by a well-established healthcare infrastructure, high orthopedic procedure volumes, and a strong presence of key orthobiologics manufacturers in the region. Other influential regions include Europe and Asia-Pacific.

DePuy Synthes, Zimmer Biomet Stryker, Bioventus, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, NuVasive, SeaSpine, Xtant Medical,